Abstract
The mechanisms by which cells evade the lethal effects of cytotoxic drugs have been the subject of intense investigation by cell and molecular biologists for more than 20 years. Much of this work was stimulated by the initial success of cancer chemotherapy in disseminated childhood cancers such as leukemias, neuroblastoma, and sarcomas, in germ-cell tumors such as choriocarcinoma and testicular cancer, and in the responsiveness of other cancers such as lymphomas, breast, and ovarian cancers. These clinical successes suggested that metastatic cancer could be cured with chemotherapy, yet in many cases promising remissions were followed by regrowth of drug-resistant cancers. The possibility of cure, coupled with the hope that a defined set of reversible resistance mechanism could be delineated, led to the intense interest in studies of drug resistance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gottesman, M. M., and Pastan, I. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:385–427.
Danø, K. (1972). Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo. Biochim. Biophys. Acta 323:466–483.
Ling, V., and Thompson, L. H. (1974). Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J. Cell. Physiol. 83:103–116.
Danø, K. (1973). Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim. Biophys. Acta 323:466–483.
Fojo, A., Akiyama, S.-i., Gottesman, M. M., and Pastan, I. (1985). Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. Cancer Res. 45:3002–3007.
Juliano, R. L., and Ling, V. (1976). A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455:152–162.
Ueda, K., Cornwell, M. M., Gottesman, M. M., Pastan, I., Roninson, I. B., Ling, V., Riordan, J. R. (1986). The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem. Biophys. Res. Commun. 141:956–962.
Shen, D.-W., Fojo, A. T., Chin, J. E., Roninson, I. B., Richert, N., Pastan, I., and Gottesman, M. M. (1986). Human multidrug resistant cell lines: Increased mdr1expression can precede gene amplification. Science 232:643–645.
Roninson, I. B., Chin, J. E., Choi, K., et al. (1986). Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. Natl. Acad. Sci. USA 83:4538–4552.
Ueda, K., Cardarelli, C, Gottesman, M. M., et al. (1987). Expression of a full-length cDNA for the human “MDR1” (P-glycoprotein) gene confers multidrug resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. USA 84:3004–3008.
Pastan, I., Gottesman, M. M., Ueda, K., et al. (1988). A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl. Acad. Sci. USA 85:4486–4490.
Gros, P., Ben Neriah, Y., Croop, J., et al. (1986). Isolation and characterization of a complementary DNA that confers multidrug resistance. Nature 323:728–731.
Gros, P., Raymond, M., Bell, J., et al. (1988). Cloning and characterization of a second member of the mouse mdr gene family. Mol. Cell Biol. 8:2770–2778.
Scotto, K. W., Biedler, J. L., and Melera, P. W. (1986). The differential amplification and expression of genes associated with multidrug-resistance in mammalian cells. Science 232:751–755.
Gerlach, J. H., Endicott, J. A., Juranka, P. R, et al. (1986). Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature 324:485–489.
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D., Pastan, I., Gottesman, M. M., and Roninson, I. B. (1986). Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47:381–389.
Ambudkar, S. V., Pastan, I., and Gottesman, M. M. (1995). Cellular and biochemical aspects of multidrug resistance. In Drug Transport in Antimicrobial and Anticancer Chemotherapy (N.H. Georgapapadakou, ed.), Dekker, New York, pp. 525–547.
Zhang, J.-T., and Ling, V. (1991). Study of membrane orientation and glycosylated extracellular loops of mouse P-glycoprotein by in vitro translation. J. Biol. Chem. 266:18224–18232.
Zhang, J. T., Duthie, M., and Ling, V. (1993). Membrane topology of the N-terminal half of the hamster P-glycoprotein molecule. J. Biol. Chem. 268:15101–15110.
Skach, W. R., Calayag, M. C, and Lingappa, V. R. (1993). Evidence for an alternate model of human P-glycoprotein structure and biogenesis. J. Biol. Chem. 268:6903–6908.
Germann, U. A., Pastan, I., and Gottesman, M. M. (1993). P-glycoproteins: Mediators of multidrug resistance. Semin. Cell Biol. 4:63–76.
Germann, U. A. (1993). Molecular analysis of the multidrug transporter. Cytotechnology 12:33–62.
Hyde, S. C, Emsley, P., Hartshorn, M. J., et al. (1990). Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance, and bacterial transport. Nature 346:362–365.
Mimura, C. S., Holbrook, S. R., and Ames, G. F.-L. (1991). Structural model of the nucleotide-binding conserved component of periplasmic permeases. Proc. Natl. Acad. Sci. USA 88:84–88.
Ames, G. F.-L., Mimura, C. S., Holbrook, S. R., et al. (1992). Traffic ATPases: A superfamily of transport proteins operating from Escherichia coli to humans. Adv. Enzymol 65:1–47.
Ames, G. F.-L., and Lecar, H. (1992). ATP-dependent bacterial transporters and cystic fibrosis: Analogy between channels and transporters. FASEB J. 6:2660–2666.
Higgins, C. F. (1992). ABC transporters—from microorganisms to man. Annu. Rev. Cell Biol. 8:67–113.
Smit, J. J. M., Schinkel, A. H., Oude Elferink, R. P. J., et al. (1993). Homozygous disruption of the murine mdr1 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451–462.
Ruetz, S., and Gros, P. (1994). Phosphatidylcholine translocase: A physiological role for the mdr1 gene. Cell 77:1071–1081.
Cole, S. P. C, Bhardwaj, G., Gerlach, J. H., et al. (1992). Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650–1654.
Riordan, J. R., Rommens, J. M., Kerem, B.-s., et al. (1989). Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245:1066–1073.
Kamijo, K., Taketani, S., Yokota, S., et al. (1989). The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP binding superfamily. J. Biol. Chem. 265:4534–4540.
Gärtner, J., Moser, H., and Valle, D. (1992). Mutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome. Nature Genet 1:16–23.
Mosser, J., Douar, A., Sarde, C, et al. (1993). Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361:726–730.
Valle, D., and Gärtner, J. (1993). Penetrating the peroxisome. Nature 361:682–683.
Monaco, J. J. (1992). Major histocompatibility complex-linked transport proteins and antigen processing. Immunol. Res. 11:125–132.
Van der Bliek, A. M., Baas, F., Ten Houte de Lange, T., et al. (1987). The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver. EMBO J. 6:3325–3331.
Van der Bliek, A. M., Kooiman, P. M., Schneider, C, et al. (1988). Sequence of mdr3 cDNA, encoding a human P-glycoprotein. Gene 71:401–411.
McGrath, J. P., and Varshavsky, A. (1989). The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein. Nature 340:400–404.
Hess, J., Wels, W., Vogel, M., et al. (1986). Nucleotide sequence of a plasmid-encoded haemolysin determinant and its comparison with a corresponding chromosomal haemolysin sequence. FEMS Microbiol. Lett. 34:1–11.
Higgins, C. F., Haag, P. D., Nikaido, K., et al. (1982). Complete nucleotide sequence and identification of membrane components of the histidine transport operon of S. typhimurium. Nature 298:723–727.
Hiles, I. D., Gallagher, M. P., Jamieson, D., et al. (1987). Molecular characterization of the oligopeptide permease of Salmonella typhimurium. J. Mol. Biol. 195:125–142.
Bell, A. W., Buckel, S. D., Groarke, J. M., et al. (1986). The nucleotide sequence of the rbsD, rbsA and rbsC genes of Escherichia coli. J. Biol. Chem. 261:7652–7658.
Kostler, W., and Braun, V. (1986). Iron hydroxamate transport of Escherichia coli: Nucleotide sequence of the fhuB gene and identification of the protein. Mol. Gen. Genet. 204:435–442.
Coulton, J. W., Mason, P., and Allatt, D. (1987). fhuC and fhuD genes for iron(III)-ferrichrome transport into Escherichia coli K-12. J. Bacteriol. 169:3844–3849.
Walker, J. E., Saraste, M., Runswick, M. J., et al. (1982). Distantly related sequences in the α- and ß-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1:945–951.
Shyamala, V, Baichwald, V, Beall, E., et al. (1991). Structure-function analysis of the histidine permease and comparison with cystic fibrosis mutations. J. Biol. Chem. 266:18714–18719.
Manavalan, P., Smith, A. E., and Mcpherson, J. M. (1993). Sequence and structural homology among membrane-associated domains of CFTR and certain transporter proteins. J. Protein Chem. 12:279–290.
Tang-Wai, D. F., Brossi, A., Arnold, L. D., et al. (1993). The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance. Biochemistry 32:6470–6476.
Kessel, D. (1989). Exploring multidrug resistance by using rhodamine 123. Cancer Commun. 1:145–149.
Weaver, J. L., Ine, P. S., Aszalos, A., et al. (1991). Laser scanning and confocal microscopy of daunorubicin, doxorubicin and rhodamine 123 in multidrug-resistant cells. Exp. Cell Res. 196:323–329.
Raviv, Y, Pollard, H. B., Bruggemann, E. P., et al. (1990). Photosensitized labeling of a functional multidrug transporter in living drugresistant tumor cells. J. Biol. Chem. 265:3975–3980.
Stein, W. D., Cardarelli, C. O., Pastan, I., et al. (1994). Kinetic evidence suggesting that the multidrug transporter differentially handies influx and efflux of its substrates. Mol. Pharmacol. 45:763–772.
Homolya, L., Hollo, Z., Germann, U. A., et al. (1993). Fluorescent cellular indicators are extruded by the multidrug resistance protein. J. Biol. Chem. 268:21493–21496.
Higgins, C. F., and Gottesman, M. M. (1992). Is the multidrug transporter a flippase? Trends Pharmacol. Sci. 17:18–21.
Gill, D. R., Hyde, S. C, Higgins, C. F, et al. (1992). Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein. Cell 71:23–32.
Valverde, M. A., Diâz, M., SepuTveda, F. V., et al. (1992). Volume-regulated chloride channels associated with the human multidrug resistance P-glycoprotein. Nature 355:830–833.
Cornwell, M. M, Gottesman, M. M, and Pastan, I. (1986). Increased vinblastine binding to membrane vesicles from multidrug resistant KB cells. J. Biol. Chem. 262:7921–7928.
Cornwell, M. M., Safa, A. R., Felsted, R. L., et al. (1986). Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150–170kDa protein detected by photoaffinity labeling. Proc. Natl. Acad. Sci. USA 83:3847–3850.
Safa, A. R., Glover, C. J., Meyets, M. B., et al. (1986). Vinblastine photoaffinity labeling of a high-molecular-weight surface membrane glycoprotein specific for multidrug-resistant cells. J. Biol. Chem. 261:6137–6140.
Bruggemann, E. P., Germann, U. A., Gottesman, M. M., et al. (1989). Two different regions of P-glycoprotein are photoaffinity labeled by azidopine. J. Biol. Chem. 264:15483–15488.
Bruggemann, E. P., Currier, S. J., Gottesman, M. M., et al. (1992). Characterization of the azidopine and vinblastine binding site of P-glycoprotein. J. Biol. Chem. 267:21020–21026.
Greenberger, L. M., Lisanti, C. J., Silva, J. T., et al. (1991). Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded mouse mdr1b. J. Biol. Chem. 266:20744–20751.
Morris, D. I., Speicher, L. A., Ruoho, A. E., et al. (1991). Interaction of forskolin with the P-glycoprotein multidrug transporter. Biochemistry 30:8371–8379.
Greenberger, L. M. (1993). Major photoaffinity drug labeling sites for iodoarylazidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domain-6 and domain-12. J. Biol. Chem. 268:11417–11425.
Tamai, I., and Safa, A. R. (1991). Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells. J. Biol. Chem. 266:16796–16800.
Buschman, E., and Gros, P. (1991). Functional analysis of chimeric genes obtained by exchanging homologous domains of the mouse mdr1 and mdr2genes. Mol. Cell. Biol. 11:595–603.
Dhir, R., and Gros, P. (1992). Functional analysis of chimeric proteins constructed by exchanging homologous domains of two P-glycoproteins conferring distinct drug resistance profiles. Biochemistry 31:6103–6110.
Currier, S. J., Kane, S. E., Willingham, M. C, et al. (1992). Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters. J. Biol. Chem. 267:25153–25159.
Currier, S. J., Ueda, K., Willingham, M. C, et al. (1989). Deletion and insertion mutants of the multidrug transporter. J. Biol. Chem. 264:14376–14381.
Choi, K., Chen, C.-J., Kriegler, M., et al. (1989). An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1(P-glycoprotein) gene. Cell 53:519–529.
Kioka, N., Tsubota, J., Kakehi, Y., et al. (1989). P-glycoprotein gene (MDR1) cDNA from human adrenal: Normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem. Biophys. Res. Commun. 162:224–231.
Safa, A. R., Stern, R. K., Choi, K., et al. (1990). Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly to Val-185 substitution in P-glycoprotein. Proc. Natl. Acad. Sci. USA 87:7225–7229.
Loo, T. W., and Clarke, D. M. (1993). Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein. J. Biol. Chem. 268:3143–3149.
Devine, S. E., Ling, V, and Melera, P. W. (1992). Amino acid substitutions in the 6th transmembrane domain of P-glycoprotein alter multidrug resistance. Proc. Natl. Acad. Sci. USA 89:4564–4568.
Loo, T. W., and Clarke, D. M. (1993). Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein. J. Biol. Chem. 268:19965–19972.
Gros, P., Dhir, R., Croop, J., et al. (1991). A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps. Proc. Natl. Acad. Sci. USA 88:7289–7293.
Kajiji, S., Talbot, F, Grizzuti, K., et al. (1993). Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain-11 as a putative drug binding site. Biochemistry 32:4185–4194.
Kajiji, S., Dreslin, J. A., Grizzuti, K., et al. (1994). Structurally distinct MDR modulators show specific patterns of reversal against P-glycoproteins bearing unique mutations at serine 939/941. Biochemistry 33:5041–5048.
Dhir, R., Grizzuti, K., Kajiji, S., et al. (1993). Modulatory effects on substrate specificity of independent mutations at the serine (939/941) position in predicted transmembrane domain-11 of P-glycoproteins. Biochemistry 32:9492–9499.
Azzaria, M., Schurr, E., and Gros, P. (1989). Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance. Mol. Cell. Biol. 9:5289–5297.
Shimabuku, A. M., Saeki, T., Ueda, K., et al.. (1991). Production of a site specifically cleavable P-glycoprotein-ß-galactosidase fusion protein. Agric. Biol. Chem. 55:1075–1080.
Shimabuku, A. M., Nishimoto, T., Ueda, K., et al. (1992). P-glycoprotein—ATP hydrolysis by the N-terminal nucleotide-binding domain. J. Biol. Chem. 267:4308–4311.
Buschman, E., Arceci, R. J., Croop, J. M., et al. (1992). mdr1 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies. J. Biol. Chem. 267:18093–18099.
Schinkel, A. H., Roelofs, M. E. M., and Borst, P. (1991). Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Cancer Res. 51:2628–2635.
Sarkadi, B., Price, E. M., Boucher, R. C, et al. (1992). Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J. Biol. Chem. 267:4854–4858.
Doige, C. A., Yu, X. H., and Sharom, F. J. (1992). ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochim. Biophys. Acta 1109:149–160.
Al-Shawi, M. K., and Senior, A. E. (1993). Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein. J. Biol. Chem. 268:4197–4206.
Al-Shawi, M. K., Urbatsch, I. L., and Senior A. E. (1994). Covalent inhibitors of P-glycoprotein ATPase activity. J. Biol. Chem. 269:8986–8992.
Shapiro, A. B., and Ling, V (1994). ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J. Biol. Chem. 269:3745–3754.
Ng, W. F., Sarangi, F., Zastawny, R. L., et al. (1989). Identification of members of the P-glycoprotein multigene family. Mol. Cell. Biol. 9:1224–1232.
Ambudkar, S. V., Lelong, I. H., Zhang, J. P., et al. (1992). Partial purification and reconstitution of the human multidrug-resistance pump—Characterization of the drug-stimulatable ATP hydrolysis. Proc. Natl. Acad. Sci. USA 89:8472–8476.
Davidson, A. L., Shuman, H. A., and Nikaido, H. (1992). Mechanism of maltose transport in Escherichia coli: Transmembrane signaling by periplasmic binding proteins. Proc. Natl. Acad. Sci. USA 89:2360–2364.
Bishop, L., Agbyani, R., Ambudkar, S. V., et al. (1989). Reconstitution of a bacterial periplasmic permease in proteoliposomes and demonstration of ATP hydrolysis concomitant with transport. Proc. Natl. Acad. Sci. USA 86:6953–6957.
Horio, M., Gottesman, M. M., and Pastan, I. (1988). ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc. Natl. Acad. Sci. USA 85:3580–3584.
Gros, P., Croop, J., and Housman, D. E. (1986). Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47:371–380.
Croop, J. M., Raymond, M., Haber, D., et al. (1989). The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol. Cell Biol. 9:1346–1350.
Chin, J. E., Chen, C.-J., Kriegler, M., et al. (1989). Structure and expression of the human MDR (P-glycoprotein) gene family. Mol. Cell. Biol. 9:3808–3820.
Cardon-Cardo, C, O’Brien, J. P., Boccia, C, et al. (1990). Expression of multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem. 38:1277–1287.
Gottesman, M. M., Willingham, M. C., Theibaut, F., et al. (1991). Expression of the MDR1 gene in normal human tissues. In Molecular and Cellular Biology of Multidrug Resistance in Tumors (I. B. Roninson, ed.), Plenum Press, New York, pp. 279–289.
Chaudhary, P. M., and Roninson, I. B. (1991). Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85–94.
Drach, D., Zhao, S. R., Drach, J., et al. (1992). Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80:2729–2734.
Chaudhary, P. M., Mechetner, E. B., and Roninson, I. B. (1992). Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80:2735–2739.
Arceci, R. J., Croop, J. M., Horwitz, S. B., et al. (1988). The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc. Natl. Acad. Sci. USA 85:4350–4354.
Arceci, R. J., Baas, F., Raponi, R., et al. (1990). Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus. Mol. Reprod. Dev. 25:101–109.
Piekarz, R. L., Cohen, D., and Horwitz, S. B. (1993). Progesterone regulates the murine multidrug resistance mdr1b gene. J. Biol. Chem. 268:7613–7616.
Bates, S. E., Mickley, L. A., Chen, Y.-N., et al. (1989). Expression of a drug resistance gene in human neuroblastoma cell lines. Mol. Cell Biol. 9:4337–4344.
Mickley, L. A., Bates, S. E., Richert, N. D., et al. (1989). Modulation of the expression of a multidrug resistance gene by differentiating agents. J. Biol. Chem. 264:18031–18040.
Frommel, T. O., Coon, J. S., Tsuruo, T., et al. (1993). Variable effects of sodium butyrate on the expression and function of the MDR1(P-glycoprotein) gene in colon carcinoma cell lines. Int. J. Cancer 55:297–302.
Burt, R. K., Garfield, S., Johnson, K., et al. (1988). Transformation of rat liver epithelial cells with v-Ha-ras or v-raf causes expression of MDR1, glutathione-S-transferase-P and increased resistance to cytotoxic chemicals. Carcinogenesis 9:2329–2332.
Chin, K.-V., Ueda, K., Pastan, I., et al. (1992). Modulation of the activity of the promoter of the human MDR1 gene by Ras and p53. Science 255:459–462.
Cornwell, M. M., and Smith, D. E. (1993). A signal transduction pathway for activation of the mdr1 promoter involves the proto-oncogene c-raf kinase. J. Biol. Chem. 268:15347–15350.
Thorgeirsson, S. S., Huber, B. E., Sorrell, S., et al. (1987). Expression of the multidrug-resistance gene in hepatocarcinogenesis and regenerating rat liver. Science 236:1120–1122.
Fairchild, C, Ivy, S., Rushmore, T., et al. (1987). Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic nodules and hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 84:7701–7705.
Gant, T. W., Silverman, J. A., Bisgaard, H. C, et al. (1991). Regulation of 2-AAF and methylcholanthrene-mediated induction of multidrug resistance and cytochrome P450IA gene family expression in primary hepatocyte cultures and rat liver. Mol. Carcinogenesis 4:499–509.
Chin, K.-V, Chauhan, S., Pastan, I., et al. (1990). Regulation of mdr gene expression in acute response to cytotoxic insults in rodent cells. Cell Growth Differ. 1:361–365.
Herzog, C. E., Tsokos, M., Bates, S. E., et al. (1993). Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. J. Biol. Chem. 268:2946–2952.
Chin, K.-V, Tanaka, S., Darlington, G., et al. (1990). Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem. 265:221–226.
Kioka, N., Yamano, Y, Komano, T., et al. (1992). Heat-shock responsive elements in the induction of the multidrug resistance gene (MDR1). FEBS Lett. 301:37–40.
Chin, K.-V, Pastan, I., and Gottesman, M. M. (1993). Function and regulation of the human multidrug resistance gene. Adv. Cancer Res. 60:157–180.
Ueda, K., Clark, D. P., Chen, C.-j., et al. (1987). The human multidrug-resistance (mdr1) gene: cDNA cloning and transcription initiation. J. Biol. Chem. 262:505–508.
Hsu, S. I., Lothstein, L., and Horwitz, S. B. (1989). Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. J. Biol. Chem. 264:12053–12062.
Ueda, K., Pastan, I., and Gottesman, M. M. (1987). Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene. J. Biol. Chem. 262:17432–17436.
Raymond, M., and Gros, P. (1990). Cell-specific activity of cis-acting regulatory elements in the promoter of the mouse multidrug resistance gene mdr1. Mol. Cell Biol. 10:6036–6040.
Cohen, D., Piekarz, R. I., Hsu, S. I., et al. (1991). Structural and functional analysis of the mouse mdr1b gene promoter. J. Biol. Chem. 266:2239–2244.
Madden, M. J., Morrow, C. S., Nakagawa, M., et al. (1993). Identification of 5′ and 3′ sequences involved in the regulation of transcription of the human mdr1 gene in vivo. J. Biol. Chem. 268:8290–8297.
Cornwell, M. M., and Smith, D. E. (1993). SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity. J. Biol. Chem. 268:19505–19511.
Zastawny, R. L., and Ling, V (1993). Structural and functional analysis of 5′ flanking and intron-1 sequences of the hamster P-glycoprotein pgp1 and pgp2 genes. Biochim. Biophys. Acta 1173:303–313.
Silverman, J. A., Raunio, H., Gant, T. W., et al. (1991). Cloning and characterization of a member of the rat multidrug resistance (mdr) gene family. Gene 106:229–236.
Ikeguchi, M., Teeter, L., Eckersberg, T., et al. (1991). Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3/mdr1a reveal a negative element containing the AP1-site. DNA Cell Biol. 10:639–649.
Teeter, L. D., Eekersberg, T., Tsai, Y., et al. (1991). Analysis of the Chinese hamster P-glycoprotein/multidrug resistance gene pgp1 reveals that the AP-1 site is essential for full promoter activity. Cell Growth Differ. 2:429–437.
Goldsmith, M. E., Madden, M. J., Morrow, C. S., et al. (1993). A y-box consensus sequence is required for basal expression of the human multidrug resistance (mdr1) gene. J. Biol. Chem. 268:5856–5860.
Ogura, M., Takatori, T., and Tsuruo, T. (1992). Purification and characterization of NF-R1 that regulates the expression of the human multidrug resistance (MDR1) gene. Nucleic Acids Res. 20:5811–5817.
Cornwell, M. M. (1990). The human multidrug-resistance (MDR1) gene: Sequences upstream and downstream of the initiation site influence transcription. Cell Growth Differ. 1:607–615.
Van Groenigen, M., Valentijn, L. J., and Baas, F. (1993). Identification of a functional initiator sequence in the human MDR1 promoter. Biochim. Biophys. Acta 1172:138–146.
Schinkel, A. H., Kemp, S., Dolle, M., et al. (1993). N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein. J. Biol. Chem. 268:7474–7481.
Beck, W. T, and Cirtain, M. (1982). Continued expression of Vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronase. Cancer Res. 42:184–189.
Ling, V., Kartner, N., Sudo, T., et al. (1983). The multidrug resistance phenotype in Chinese hamster ovary cells. Cancer Treat. Rep. 67:869–874.
Center, M. S. (1985). Mechanisms regulating cell resistance to adriamycin: Evidence that drug accumulation in resistant cells is modulated by phosphorylation of a plasma membrane glycoprotein. Biochem. Pharmacol. 34:1471–1476.
Mellado, W., and Horwitz, S. B. (1987). Phosphorylation of the multidrug resistance associated glycoprotein. Biochemistry 26:6900–6904.
Hamada, H., Hagiwara, K.-I., Nakajima, T., et al. (1987). Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: Effects of verapamil, trifluoperazine, and phorbol esters. Cancer Res. 47:2860–2865.
Fine, R. L., Patel, J., and Chabner, B. A. (1988). Phorbol esters induce multidrug resistance in human breast cancer cells. Proc. Natl. Acad. Sci. USA 85:582–586.
Epand, R. M., and Stafford, A. R. (1993). Protein kinases and multidrug resistance. Cancer J. 6:154–158.
Chambers, T. C, McAvoy, E. M., Jacobs, J. W., et al. (1990). Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J. Biol. Chem. 265:7679–7686.
Ahmad, S., Trepel, J. B., Ohno, S., et al. (1992). Role of protein kinase-C in the modulation of multidrug resistance—Expression of the atypical gamma-isoform of protein kinase-C does not confer increased resistance to doxorubicin. Mol. Pharmacol. 42:1004–1009.
Ahmad, S., and Glazer, R. I. (1993). Expression of the antisense cDNA for protein kinase-C-alpha attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells. Mol. Pharmacol. 43:858–862.
Chaudhary, P. M., and Roninson, I. B. (1992). Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase-C agonists. Oncol. Res. 4:281–290.
Bates, S. E., Lee, J. S., Dickstein, B., et al. (1993). Differential modulation of P-glycoprotein transport by protein kinase inhibition. Biochemistry 32:9156–9164.
Chambers, T. C, Pohl, J., Raynor, R. L., et al. (1993). Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase-C. J. Biol. Chem. 268:4592–4595.
Orr, G. A., Han, E. K.-H., Browne, P. C, et al. (1993). Identification of the major phosphorylation domain of murine mdr1b P-glycoprotein. J. Biol. Chem. 268:25054–25062.
Riordan, J. R. (1993). The cystic fibrosis transmembrane conductance regulator. Annu. Rev. Physiol. 55:609–630.
Gottesman, M. M. (1993). How cancer cells evade chemotherapy—Sixteenth Richard and Linda Rosenthal Foundation Award Lecture. Cancer Res. 53:747–754.
Galski, H., Sullivan, M., Willingham, M. C, et al. (1989). Expression of a human multidrug-resistance cDNA(MDR1) in the bone marrow of transgenic mice: Resistance to daunomycin-induced leukopenia. Mol. Cell. Biol. 9:4357–4363.
Mickisch, G., Merlino, G. T., Galski, H., et al. (1991). Transgenic mice that express the human multidrug resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance. Proc. Natl. Acad. Sci. USA 88:547–551.
Mickisch, G. H., Aksentijevich, I., Schoenlein, P. V., et al. (1992). Transplantation of bone marrow cells from transgenic mice expressing the human MDR1 gene results in long-term protection against the myelosuppressive effect of chemotherapy in mice. Blood 79:1–7.
Sorrentino, B. P., Brandt, S. J., Bodine, D., et al. (1992). Retroviral transfer of the human MDR1 gene permits selection of drug resistant bone marrow cells in vivo. Science 257:99–103.
Podda, S., Ward, M., Himelstein, A., et al. (1992). Transfer and expression of the human multiple drug resistance gene into live mice. Proc. Natl. Acad. Sci. USA 89:9676–9680.
Cardarelli, C. O., Aksentijevich, I., Pastan I., et al. (1995). Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters. Cancer Res. 55:1086–1091.
Germann, U. A., Chambers, T. C, Ambudkar, S. V., et al. (1996). Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells. J. Bio. Chem. 271:1708–1716.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Plenum Press, New York
About this chapter
Cite this chapter
Gottesman, M.M., Ambudkar, S.V., Cornwell, M.M., Pastan, I., Germann, U.A. (1996). Multidrug Resistance Transporter. In: Schultz, S.G., Andreoli, T.E., Brown, A.M., Fambrough, D.M., Hoffman, J.F., Welsh, M.J. (eds) Molecular Biology of Membrane Transport Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1143-0_13
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1143-0_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8446-8
Online ISBN: 978-1-4613-1143-0
eBook Packages: Springer Book Archive